Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(40.0%)
N/A
2(40.0%)
Phase 4
1(20.0%)
5Total
Phase 1(2)
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06137950Phase 1Completed

Interferon Alpha Therapy for Cervical CINI and HPV Infection

Role: lead

NCT04126135Phase 4Completed

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy

Role: collaborator

NCT05852002Not ApplicableCompleted

A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer

Role: collaborator

NCT06132542Phase 1Unknown

Autologous ADMSC Transplantation in Patients With POI

Role: lead

NCT05764226Not ApplicableCompleted

Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds

Role: collaborator

All 5 trials loaded